Accelerated hypertension--patterns of mortality and clinical factors affecting outcome in treated patients.
We evaluated the outcome of patients presenting with accelerated hypertension, as part of an audit of the Aberdeen Hypertension Clinic database. Of 3928 patients (2005 male, 1923 female) referred for assessment of hypertension, 128 (77 male, 51 female) presented with accelerated hypertension. The main outcome measures were systolic and diastolic pressure, length of time from referral to death or censor date, and cause of death. Accelerated hypertensives had a higher death rate than other hypertensives. Using life-table analysis, age and serum creatinine at referral were sufficient to predict survival. Almost 50% (15/31) of the deceased accelerated hypertensives died of acute myocardial infarction. Mean survival after referral was estimated as 18 years for accelerated hypertensives (mean referral age 52 years) and 21 years for other hypertensives (mean referral age 48 years). Blood pressure fell most during the first year of treatment, and declined steadily thereafter. Systolic blood pressure fell by a mean of 50 mmHg and diastolic pressure by 30 mmHg in the first year, and at about 2 (diastolic) and 1 (systolic) mmHg/year for the next 10 years. Thus although the prognosis for accelerated hypertensives is not quite as good as for other hypertensives, with suitable care they can survive for a considerable period.
Webster
J
J
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, UK.
Petrie
J C
JC
Jeffers
T A
TA
Lovell
H G
HG
D000328:Adult; D000368:Aged; D001794:Blood Pressure; D002423:Cause of Death; D005260:Female; D006801:Humans; D006973:Hypertension / Q000401:mortality* / Q000503:physiopathology; D015993:Life Tables; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012017:Referral and Consultation; D012307:Risk Factors; D012606:Scotland / Q000453:epidemiology; D013997:Time Factors